Massy Z A, Mazière C, Kamel S, Brazier M, Choukroun G, Tribouilloy C, Slama M, Andrejak M, Mazière J C
EA2087, Amiens University Hospital, UPJV, Amiens, France.
Pediatr Nephrol. 2005 Mar;20(3):380-2. doi: 10.1007/s00467-004-1623-9. Epub 2004 Nov 10.
Vascular and/or valvular calcifications in patients with chronic kidney disease (CKD) appear to indicate a poor prognosis in terms of overall survival and cardiovascular morbidity and mortality. Inflammation and oxidative stress represent new features of the arterial and/or valvular calcification process. However, only limited observational and epidemiological data are available in these areas. Therefore, the link between inflammation, oxidation and vascular and/or valvular calcifications deserves careful consideration in CKD patients, since they may become targets for the development of new therapeutic strategies.